bamlanivimab 7000mg
A5401/ACTIV-2
Phase 3 mab completed
Quick answer
bamlanivimab 7000mg for Coronavirus is a Phase 3 program (mab) at SAB Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SAB Biotherapeutics
- Indication
- Coronavirus
- Phase
- Phase 3
- Modality
- mab
- Status
- completed